FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

ALBERTDAVD Share Price Discussion

Albert David Ltd.
Sector: Pharmaceuticals and health care
... Read more
ALBERTDAVD Share Price *
405 -1.65 (-0.41%)
* (quote may be delayed)

Find answers to all your questions on live ALBERTDAVD message board: Is ALBERTDAVD buy or sell? Should I buy ALBERTDAVD shares? Why are ALBERTDAVD shares falling? Should I invest in ALBERTDAVD stock?


ALBERTDAVD Discussion Forum

Albert David Standalone June 2019 Net Sales at Rs 91.62 crore, down 2.95% Y-o-Y
moneycontrol.com
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
  • ALBERTDAVD - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization208.1
    Enterprise Value210.08
    Price to Earnings21.15
    Price to Book Value1.12
    Return on Capital Employed0.09
    Return on Equity0.05
    Face Value10
    Dividend Yield0.02
  • ALBERTDAVD Share Price - Technicals

    keyboard_arrow_down
    ALBERTDAVD - 52 Week High₹509
    ALBERTDAVD - 52 Week Low₹315
  • ALBERTDAVD Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Dec 9403410.05402.15404.7
    Dec 6414415.95404.1406.65
    Dec 5415.75416404.85412
    Dec 4400.55414.7400405.2
    Dec 3400.05405.1399.95401.15
  • ALBERTDAVD Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹409.95
    30 Day Moving Average₹403.41
    50 Day Moving Average₹381.93
    100 Day Moving Average₹371.83
    200 Day Moving Average₹388.21
  • ALBERTDAVD - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue287.45304.62-0.06
    Operating Profit18.2325.19-0.28
    Profit Before Tax17.920.24-0.12
    Net Income9.8412.04-0.18
  • ALBERTDAVD - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds185.95148.870.25
    Total Liabilities105.5698.450.07
    Total Assets291.51247.320.18
  • ALBERTDAVD - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity30.0119.670.53
    Cash from Investing Activity-10.83-36-0.7
    Cash from Financing Activity-4.569.16-1.5
    Net Cash Flow14.63-7.16-3.04
  • ALBERTDAVD - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.030.05
    Return on Equity0.050.08
    Return on Capital Employed0.090.12
  • ALBERTDAVD - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.11
    3 Year CAGR Growth in Operating Profit10.99
    3 Year CAGR Growth in EBIDTA-0.3
    3 Year CAGR Growth in Net Income-0.28
    3 Yr CAGR Growth - Diluted EPS-0.28
  • ALBERTDAVD - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.08
    5 Year CAGR Growth in Operating Profit-0.3
    5 Year CAGR Growth in EBIDTA-0.02
    5 Year CAGR Growth in Net Income0.15
    3 Yr CAGR Growth - Diluted EPS0.15
  • ALBERTDAVD - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 12 8:33 PM
    Albert David Standalone June 2019 Net Sales at Rs 91.62 crore, down 2.95% Y-o-Y
    moneycontrol.com
    NewsBot
    Jul 5 6:33 PM
    NewsBot
    May 30 8:08 PM
    NewsBot
    Nov 30 1:47 PM
  • ALBERTDAVD - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.